Short answer
PRO DEX INC (PDEX) filed its Q4 2025 10-Q quarterly report on Jan 29, 2026 for the quarter ended Dec 31, 2025. Quarterly revenue was $19M (up 11.1% year over year) with net income of $2M.
Q4 2025 key financials · XBRL
- Revenue
- $19M
- +11.1% YoY · +0.7% QoQ
- Net income
- $2M
- +7.2% YoY · −53.3% QoQ
- Operating margin
- 17.5%
- Gross margin
- 30.8%
- EPS (diluted)
- $0.67
- +15.5% YoY · −52.1% QoQ
Source: XBRL data from the PRO DEX INC (PDEX) Q4 2025 10-Q on SEC EDGAR. USD.
PRO DEX INC Q4 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $18.663M, up 11% YoY from $16.793M
- Gross margin 31% vs 30% YoY
- Orthopedic sales $11.884M, up 27%; thoracic sales $183K, down 83%
- Cash $8.0M vs $419K at June 30; operating cash flow $5.9M vs $(2.3)M
- Backlog $37.4M; expected orthopedic growth through fiscal year-end, with potential legacy repair declines
Risk Factors
- No material changes to risk factors from the June 30, 2025 Form 10-K
- Carried-forward risks include business, financial-condition, and operating-results uncertainties
- SEC filings identify additional risks beyond those disclosed in the Form 10-K
- No new regulatory, legal, operational, competitive, market, or financial risk disclosed this quarter
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other PRO DEX INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.